EHS
EHS

Clustering of Parkinson subtypes reveals strong influence of DRD2 polymorphism and gender


  • Erkkinen, M. G., Kim, M.-O. & Geschwind, M. D. Clinical neurology and epidemiology of the major neurodegenerative diseases. Cold Spring Harb. Perspect. Biol. 10, a033118 (2018).

    Article 

    Google Scholar
     

  • Foltynie, T., Brayne, C. & Barker, R. A. The heterogeneity of idiopathic Parkinson’s disease. J. Neurol. 249, 138–145 (2002).

    Article 

    Google Scholar
     

  • Spiegel, J. et al. Striatal FP-CIT uptake differs in the subtypes of early Parkinson’s disease. J. Neural Transm. Gen. Sect. JNT 114, 331–335 (2007).

    CAS 
    Article 

    Google Scholar
     

  • Fahn, S. E. R. UPDRS program members. Unified Parkinsons Disease Rating Scale. Maximil. Healthc. Inf. 2, 153–163 (1987).


    Google Scholar
     

  • Goetz, C. G. et al. Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations. Mov. Disord. 19, 1020–1028 (2004).

    Article 

    Google Scholar
     

  • Pfeiffer, R. F. Non-motor symptoms in Parkinson’s disease. Parkinsonism Relat. Disord. 22(Suppl 1), S119-122 (2016).

    Article 

    Google Scholar
     

  • Everitt, B. S., Landau, S. & Leese, M. Cluster Analysis (Taylor & Francis, 2001).

    MATH 

    Google Scholar
     

  • van Rooden, S. M. et al. Clinical subtypes of Parkinson’s disease. Mov. Disord. 26, 51–58 (2011).

    Article 

    Google Scholar
     

  • Erro, R. et al. The heterogeneity of early Parkinson’s disease: A cluster analysis on newly diagnosed untreated patients. PLoS One 8, e70244 (2013).

    ADS 
    CAS 
    Article 

    Google Scholar
     

  • Ma, L.-Y., Chan, P., Gu, Z.-Q., Li, F.-F. & Feng, T. Heterogeneity among patients with Parkinson’s disease: Cluster analysis and genetic association. J. Neurol. Sci. 351, 41–45 (2015).

    Article 

    Google Scholar
     

  • Pont-Sunyer, C. et al. The onset of nonmotor symptoms in Parkinson’s disease (the ONSET PD study). Mov. Disord. 30, 229–237 (2015).

    Article 

    Google Scholar
     

  • Mu, J. et al. Parkinson’s disease subtypes identified from cluster analysis of motor and non-motor symptoms. Front. Aging Neurosci. 9, 301 (2017).

    Article 

    Google Scholar
     

  • Wooten, G. F., Currie, L. J., Bovbjerg, V. E., Lee, J. K. & Patrie, J. Are men at greater risk for Parkinson’s disease than women?. J. Neurol. Neurosurg. Psychiatry 75, 637–639 (2004).

    CAS 
    Article 

    Google Scholar
     

  • Haaxma, C. A. et al. Gender differences in Parkinson’s disease. J. Neurol. Neurosurg. Psychiatry 78, 819–824 (2007).

    Article 

    Google Scholar
     

  • Magistrelli, L. et al. Polymorphisms of dopamine receptor genes and Parkinson’s disease: Clinical relevance and future perspectives. Int. J. Mol. Sci. 22, 3781 (2021).

    CAS 
    Article 

    Google Scholar
     

  • McGuire, V. et al. Association of DRD2 and DRD3 polymorphisms with Parkinson’s disease in a multiethnic consortium. J. Neurol. Sci. 307, 22–29 (2011).

    CAS 
    Article 

    Google Scholar
     

  • Yu, M., Huang, F., Wang, W. & Zhao, C. Association between the DRD2 TaqIA gene polymorphism and Parkinson disease risk: An updated meta-analysis. Medicine 98, e17136 (2019).

    CAS 
    Article 

    Google Scholar
     

  • McDonell, K. E., van Wouwe, N. C., Harrison, M. B., Wylie, S. A. & Claassen, D. O. Taq1A polymorphism and medication effects on inhibitory action control in Parkinson disease. Brain Behav. 8, e01008 (2018).

    Article 

    Google Scholar
     

  • Paus, S. et al. The DRD2 TaqIA polymorphism and demand of dopaminergic medication in Parkinson’s disease. Mov. Disord. 23, 599–602 (2008).

    Article 

    Google Scholar
     

  • Kwak, Y. et al. Task-dependent interactions between dopamine D2 receptor polymorphisms and L-DOPA in patients with Parkinson’s disease. Behav. Brain Res. 245, 128–136 (2013).

    ADS 
    CAS 
    Article 

    Google Scholar
     

  • Masellis, M. et al. Dopamine D2 receptor gene variants and response to rasagiline in early Parkinson’s disease: A pharmacogenetic study. Brain 139, 2050–2062 (2016).

    Article 

    Google Scholar
     

  • Bhattacharjee, S., Hughes, E. & Ng, K. L. Rasagiline sensitive dopamine D2 receptor gene variants: A step forward toward more personalized antiparkinsonian therapy. Mov. Disord. Clin. Pract. 4, 181–182 (2016).

    Article 

    Google Scholar
     

  • Picillo, M. et al. The relevance of gender in Parkinson’s disease: A review. J. Neurol. 264, 1583–1607 (2017).

    Article 

    Google Scholar
     

  • Pelzer, E. A. et al. Axonal degeneration in Parkinson’s disease—Basal ganglia circuitry and D2 receptor availability. NeuroImage. Clin. 23, 101906 (2019).

    Article 

    Google Scholar
     

  • Baumann, C. R., Held, U., Valko, P. O., Wienecke, M. & Waldvogel, D. Body side and predominant motor features at the onset of Parkinson’s disease are linked to motor and nonmotor progression. Mov. Disord. 29, 207–213 (2014).

    Article 

    Google Scholar
     

  • Sun, X., Luquet, S. & Small, D. M. DRD2: Bridging the genome and ingestive behavior. Trends Cogn. Sci. 21, 372–384 (2017).

    Article 

    Google Scholar
     

  • Ponce, G. et al. The addiction-related gene Ankk1 is oppositely regulated by D1R- and D2R-like dopamine receptors. Neurotox. Res. 29, 345–350 (2016).

    CAS 
    Article 

    Google Scholar
     

  • Pérez-Santamarina, E. et al. Regulatory rare variants of the dopaminergic gene ANKK1 as potential risk factors for Parkinson’s disease. Sci. Rep. 11, 9879 (2021).

    ADS 
    Article 

    Google Scholar
     

  • Feis, D.-L., Pelzer, E. A., Timmermann, L. & Tittgemeyer, M. Classification of symptom-side predominance in idiopathic Parkinson’s disease. NPJ Parkinsons Dis. 1, 15018 (2015).

    Article 

    Google Scholar
     

  • Heinrichs-Graham, E., Santamaria, P. M., Gendelman, H. E. & Wilson, T. W. The cortical signature of symptom laterality in Parkinson’s disease. NeuroImage. Clin. 14, 433–440 (2017).

    Article 

    Google Scholar
     

  • Wang, J., Liu, Z. L. & Chen, B. Association study of dopamine D2, D3 receptor gene polymorphisms with motor fluctuations in PD. Neurology 56, 1757–1759 (2001).

    CAS 
    Article 

    Google Scholar
     

  • Oliveri, R. L. et al. Dopamine D2 receptor gene polymorphism and the risk of levodopa-induced dyskinesias in PD. Neurology 53, 1425–1430 (1999).

    CAS 
    Article 

    Google Scholar
     



  • Source link

    EHS
    Back to top button